These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2039692)

  • 1. Generation of bispecific monoclonal antibodies for two phase radioimmunotherapy.
    Bosslet K; Steinstraesser A; Hermentin P; Kuhlmann L; Bruynck A; Magerstaedt M; Seemann G; Schwarz A; Sedlacek HH
    Br J Cancer; 1991 May; 63(5):681-6. PubMed ID: 2039692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
    Griffiths GL; Govindan SV; Sharkey RM; Fisher DR; Goldenberg DM
    J Nucl Med; 2003 Jan; 44(1):77-84. PubMed ID: 12515879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo comparison of CHX-DTPA ligand isomers in athymic mice bearing carcinoma xenografts.
    Roselli M; Milenic DE; Brechbiel MW; Mirzadeh S; Pippin CG; Gansow OA; Colcher D; Schlom J
    Cancer Biother Radiopharm; 1999 Jun; 14(3):209-20. PubMed ID: 10850305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts.
    Roselli M; Schlom J; Gansow OA; Raubitschek A; Mirzadeh S; Brechbiel MW; Colcher D
    J Nucl Med; 1989 May; 30(5):672-82. PubMed ID: 2785585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of tumor response to experimental radioimmunotherapy with 90Y in nude mice.
    Dillehay LE; Mayer R; Zhang YG; Shao Y; Song SY; Mackensen DG; Williams JR
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):417-27. PubMed ID: 7673029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of a DTPA chelate conjugate for monoclonal antibody targeting to a human colonic tumor in nude mice.
    Sharkey RM; Motta-Hennessy C; Gansow OA; Brechbiel MW; Fand I; Griffiths GL; Jones AL; Goldenberg DM
    Int J Cancer; 1990 Jul; 46(1):79-85. PubMed ID: 2114375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma.
    Kranenborg MH; Boerman OC; Oosterwijk-Wakka JC; de Weijert MC; Corstens FH; Oosterwijk E
    Cancer Res; 1995 Dec; 55(23 Suppl):5864s-5867s. PubMed ID: 7493361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-phase radioimmunotherapy using bispecific monoclonal antibodies (bs MAbs).
    Bosslet K; Hermentin P; Kuhlmann L; Steinstraesser A; Seemann G; Sedlacek HH
    Cancer Treat Rev; 1990 Sep; 17(2-3):355-6. PubMed ID: 2272051
    [No Abstract]   [Full Text] [Related]  

  • 9. Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.
    Kraeber-Bodéré F; Faibre-Chauvet A; Saï-Maurel C; Gautherot E; Fiche M; Campion L; Le Boterff J; Barbet J; Chatal JF; Thédrez P
    J Nucl Med; 1999 Jan; 40(1):198-204. PubMed ID: 9935077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of a humanised bispecific monoclonal antibody for cancer therapy.
    Bruynck A; Seemann G; Bosslet K
    Br J Cancer; 1993 Mar; 67(3):436-40. PubMed ID: 8439495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunotherapy of human colorectal carcinoma xenografts using 90Y-labeled monoclonal antibody CO17-1A prepared by two bifunctional chelate techniques.
    Lee YC; Washburn LC; Sun TT; Byrd BL; Crook JE; Holloway EC; Steplewski Z
    Cancer Res; 1990 Aug; 50(15):4546-51. PubMed ID: 2164441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallium-68 chelate imaging of human colon carcinoma xenografts pretargeted with bispecific anti-CD44V6/anti-gallium chelate antibodies.
    Klivényi G; Schuhmacher J; Patzelt E; Hauser H; Matys R; Moock M; Regiert T; Maier-Borst W
    J Nucl Med; 1998 Oct; 39(10):1769-76. PubMed ID: 9776285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG; Oosterwijk E; Molkenboer-Kuenen JD; Soede AC; McBride BJ; Goldenberg DM; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2005 Mar; 46(3):495-501. PubMed ID: 15750164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CaNa2EDTA for improvement of radioimmunodetection and radioimmunotherapy with 111In and 90Y-DTPA-anti-CEA MAbs in nude mice bearing human colorectal cancer.
    Watanabe N; Oriuchi N; Endo K; Inoue T; Kuroki M; Matsuoka Y; Tanada S; Murata H; Kim EE; Sasaki Y
    J Nucl Med; 2000 Feb; 41(2):337-44. PubMed ID: 10688120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionated radioimmunotherapy with ⁹⁰Y-labeled fully human anti-CEA antibody.
    Hanaoka H; Kuroki M; Yamaguchi A; Achmad A; Iida Y; Higuchi T; Oriuchi N; Tsushima Y; Endo K
    Cancer Biother Radiopharm; 2014 Mar; 29(2):70-6. PubMed ID: 24299067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
    Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct measurement of intratumor dose-rate distributions in experimental xenografts treated with 90Y-labeled radioimmunotherapy.
    Mayer R; Dillehay LE; Shao Y; Zhang YG; Song S; Bartholomew RM; Mackenson DG; Williams JR
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):147-57. PubMed ID: 7721611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoembryonic antigen expression of resurgent human colon carcinoma after treatment with therapeutic doses of 90Y-alpha-carcinoembryonic antigen monoclonal antibody.
    Esteban JM; Kuhn JA; Felder B; Wong JY; Battifora H; Beatty JD; Wanek PM; Shively JE
    Cancer Res; 1991 Jul; 51(14):3802-6. PubMed ID: 2065334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 90Y.B72.3 against pancreatic cancer: dosimetric and biological analysis.
    Mehta MP; Kubsad SS; Fowler JF; Verma AK; Hsieh JT; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):627-31. PubMed ID: 2211210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.